Management of adult asthma and chronic rhinitis as one airway disease

References

• Hellings PW, Klimek L, Cingi C, Fokkens WJ. et al. Non-allergic rhinitis: Position paper of the European academy of allergy and clinical immunology. Allergy. 2017;72(11):1657–1665.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on Asthma (ARIA) 2008 update (in collaboration with the world health organization, GA(2)LEN and allerGen). Allergy. 2008;63(Suppl 86):8–160.
   PubMed Web of Science ®Google Scholar
• GINA Reports. Global Initiative for Asthma - GINA. [cited 2020 Dec 20]. Available from: https://ginasthma.org/gina-reports. Date last accessed:December 21, 2020
   Google Scholar
• Tiotiu A, Plavec D, Novakova S, et al. Current opinions for the management of asthma associated with ear, nose and throat comorbidities. Eur Respir Rev. 2018;27(150):180056.
   PubMed Web of Science ®Google Scholar
• Licari A, Manti S, Ciprandi G. What are the effects of rhinitis on patients with asthma? Expert Rev Respir Med. 2019;13(6):503–505.
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Caimmi D. Miraglia Del Giudice M, La Rosa M, Salpietro C, Marseglia GL. Recent developments in united airways disease. Allergy Asthma Immunol Res. 2012;4(4):171–177.
   PubMed Web of Science ®Google Scholar
• Brożek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140(4):950–958.
   PubMed Web of Science ®Google Scholar
• Tohidinik HR, Mallah N, Takkouche B. History of allergic rhinitis and risk of asthma; a systematic review and meta-analysis. World Allergy Organ J. 2019;12:100069.
   PubMed Web of Science ®Google Scholar
• Pinart M, Keller T, Reich A, et al. Sex-related allergic rhinitis prevalence switch from childhood to adulthood: a systematic review and meta-analysis. Int Arch Allergy Immunol. 2017;172(4):224–235.
   PubMed Web of Science ®Google Scholar
• Guo H, Peng T, Luo P, et al. Association of FcεRIβ polymorphisms with risk of asthma and allergic rhinitis: evidence based on 29 case-control studies. Biosci Rep. 2018;38(4):BSR20180177.
   PubMed Web of Science ®Google Scholar
• Khan SJ, Dharmage SC, Matheson MC, et al. Is the atopic march related to confounding by genetics and early-life environment? A systematic review of sibship and twin data. Allergy. 2018;73(1):17–28.
   PubMed Web of Science ®Google Scholar
• Bertelsen RJ, Rava M, Carsin AE, et al. Clinical markers of asthma and IgE assessed in parents before conception predict asthma and hayfever in the offspring. Clin Exp Allergy. 2017;47(5):627–638.
   PubMed Web of Science ®Google Scholar
• Pawlak EA, Noah TL, Zhou H, et al. Diesel exposure suppresses natural killer cell function and resolution of eosinophil inflammation: a randomized controlled trial of exposure in allergic rhinitics. Part Fibre Toxicol. 2016;13(1):24.
   PubMed Web of Science ®Google Scholar
• Skaaby T, Taylor AE, Jacobsen RK, et al. Investigating the causal effect of smoking on hay fever and asthma: a Mendelian randomization meta-analysis in the CARTA consortium. Sci Rep. 2017;7(1):2224. 22.
   PubMed Web of Science ®Google Scholar
• Tiotiu AI, Novakova S, Labor M, et al. Progress in Occupational Asthma. Int J Environ Res Public Health. 2020;17(12):4553.
   Web of Science ®Google Scholar
• Tiotiu A, Oster JP, Roux PR, et al. Effectiveness of omalizumab in severe allergic asthma and nasal polyposis: a real-life study. J Investig Allergol Clin Immunol. 2020;30:49–57.
   PubMed Web of Science ®Google Scholar
• Bardei F, Bouziane H, Kadiri M, et al. Skin sensitisation profiles to inhalant allergens for patients in tétouan city (north west of morocco). Rev Pneumol Clin. 2016;72(4):221–227.
   PubMed Web of Science ®Google Scholar
• Alimuddin S, Rengganis I, Rumende CM, et al. Comparison of specific immunoglobulin e with the skin prick test in the diagnosis of house dust mites and cockroach sensitization in patients with asthma and/or allergic rhinitis. Acta Med Indones. 2018;50(2):125–131.
   PubMed Web of Science ®Google Scholar
• Sánchez-Borges M, Capriles-Hulett A, Torres J, et al. Diagnosis of allergic sensitization in patients with allergic rhinitis and asthma in a tropical environment. Rev Alerg Mex. 2019;66(1):44–54.
   PubMedGoogle Scholar
• Coskun ZO, Erdivanlı OC, Kazıkdas KÇ, et al. High sensitization to house-dust mites in patients with allergic rhinitis in the eastern Black Sea region of Turkey: a retrospective study. Am J Rhinol Allergy. 2016;30(5):351–355.
   PubMed Web of Science ®Google Scholar
• Tham EH, Lee AJ, Bever HV. Aeroallergen sensitization and allergic disease phenotypes in Asia. Asian Pac J Allergy Immunol. 2016;34(3):181–189.
   PubMed Web of Science ®Google Scholar
• Wise SK, Lin SY, Toskala E. International consensus statement on allergy and rhinology: allergic rhinitis-executive summary. Int Forum Allergy Rhinol. 2018;8(2):85–107.
   PubMed Web of Science ®Google Scholar
• Okano M, Kariya S, Ohta N, et al. Association and management of eosinophilic inflammation in upper and lower airways. Allergol Int. 2015;64(2):131–138.
   PubMed Web of Science ®Google Scholar
• Tschopp JM, Sistek D, Schindler C, et al. Current allergic asthma and rhinitis: diagnostic efficiency of three commonly used atopic markers (IgE, skin prick tests, and Phadiatop). Results from 8329 randomized adults from the SAPALDIA study. swiss study on air pollution and lung diseases in adults. Allergy. 1998;53(6):608–613.
   PubMed Web of Science ®Google Scholar
• Oka A, Hirano T, Yamaji Y, et al. Determinants of Incomplete Asthma Control in Patients with Allergic Rhinitis and Asthma. J Allergy Clin Immunol Pract. 2017;5:160–164.
   PubMed Web of Science ®Google Scholar
• Belhassen M, Demoly P, Bloch-Morot E, et al. Costs of perennial allergic rhinitis and allergic asthma increase with severity and poor disease control. Allergy. 2017;72:948–958.
   PubMed Web of Science ®Google Scholar
• Sukhan VS. Allergic rhinitis and asthma co-morbidity. Wiad Lek. 2019;72(4):622–626.
   PubMedGoogle Scholar
• Lin J, Gao J, Lai K, et al. The characteristic of asthma control among nasal diseases population: Results from a cross-sectional study. eCollection 2018 PLoS ONE. 2018;13(2):e0191543.
   PubMed Web of Science ®Google Scholar
• Ohta K, Tanaka H, Tohda Y, et al. Asthma exacerbations in patients with asthma and rhinitis: Factors associated with asthma exacerbation and its effect on QOL in patients with asthma and rhinitis. Allergol Int. 2019;68(4):470–477.
   PubMed Web of Science ®Google Scholar
• Huang K, Yang T, Xu J, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019;394(10196):407–418.
   PubMed Web of Science ®Google Scholar
• Kang H-R, Song HJ, Nam JH, et al. Risk factors of asthma exacerbation based on asthma severity: a nationwide population-based observational study in South Korea. BMJ Open. 2018;8(3):e020825.
   PubMed Web of Science ®Google Scholar
• Bui DS, Lodge CJ, Burgess JA, et al. Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life. Lancet Respir Med. 2018;6(7):535–544.
   PubMed Web of Science ®Google Scholar
• Iyer A, Athavale A. Nasal airway resistance and latent lower airway involvement in allergic rhinitis. J Assoc Physicians India. 2020;68(3):43–47.
   PubMedGoogle Scholar
• Madonini E, Briatico-Vangosa G, Pappacoda A, et al. Seasonal increase of bronchial reactivity in allergic rhinitis. J Allergy Clin Immunol. 1987;79(2):358–363.
   PubMed Web of Science ®Google Scholar
• Schramm D, Reuter M, Grabenhenrich LB, et al. What does lung function tell us about respiratory multimorbidity in childhood and early adulthood? Results from the MAS birth cohort study. Pediatr Allergy Immunol. 2018;29(5):481–489.
   PubMed Web of Science ®Google Scholar
• Takahara D, Kono T, Takeno S, et al. Nasal nitric oxide in the inferior turbinate surface decreases with intranasal steroids in allergic rhinitis: a prospective study. Auris Nasus Larynx. 2019;46(4):507–512.
   PubMed Web of Science ®Google Scholar
• Duong-Quy S, Vu-Minh T, Hua-Huy T, et al. Study of nasal exhaled nitric oxide levels in diagnosis of allergic rhinitis in subjects with and without asthma. J Asthma Allergy. 2017;10:75–82.
   PubMed Web of Science ®Google Scholar
• Asano T, Takemura M, Kanemitsu Y, et al. Combined measurements of fractional exhaled nitric oxide and nasal nitric oxide levels for assessing upper airway diseases in asthmatic patients. J Asthma. 2018;55(3):300–309.
   PubMed Web of Science ®Google Scholar
• Ren L, Zhang W, Zhang Y, et al. Nasal nitric oxide is correlated with nasal patency and nasal symptoms. Allergy Asthma Immunol Res. 2019;11(3):367–380.
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Schiavetti I, Rindone E, et al. The impact of anxiety and depression on outpatients with asthma. Ann Allergy Asthma Immunol. 2015;115(5):408–414.
   PubMed Web of Science ®Google Scholar
• Calderón MA, Kleine-Tebbe J, Linneberg A, Hernandez Fernandez de Rojas D, Virchow JC, Demoly P. et al. House dust mite respiratory allergy: An overview of current therapeutic strategies. J Allergy Clin Immunol Pract. 2015;3(6):843–855.
   PubMed Web of Science ®Google Scholar
• Arbes SJ, Cohn RD, Yin M, et al. House dust mite allergen in US beds: results from the first national survey of lead and allergens in housing. J Allergy Clin Immunol. 2003;111(2):408–414.
   PubMed Web of Science ®Google Scholar
• Platts-Mills TA, Vaughan JW, Carter MC, et al. The role of intervention in established allergy: avoidance of indoor allergens in the treatment of chronic allergic disease. J Allergy Clin Immunol. 2000;106(5):787–804.
   PubMed Web of Science ®Google Scholar
• Sublett JL. Effectiveness of air filters and air cleaners in allergic respiratory diseases: a review of the recent literature. Curr Allergy Asthma Rep. 2011;11(5):395–402.
   PubMed Web of Science ®Google Scholar
• Sharpe R, Thornton CR, Osborne NJ. Modifiable factors governing indoor fungal diversity and risk of asthma. Clin Exp Allergy. 2014;44(5):631–641.
   PubMed Web of Science ®Google Scholar
• Valenta R, Niederberger V. Recombinant allergens for immunotherapy. J Allergy Clin Immunol. 2007;119(4):826–830.
   PubMed Web of Science ®Google Scholar
• Novakova P, Tiotiu A, Baiardini I, et al. Allergen immunotherapy in asthma: current evidence. J Asthma. 2021;58:223-230
   Google Scholar
• Demoly P, Emminger W, Rehm D, et al. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: results from a randomized, double-blind, placebo-controlled phase III trial. J Allergy Clin Immunol. 2016;137(444–451.e8):444–451.e8.
   Google Scholar
• Chan AW-M, Luk WP, Fung LH, et al. The effectiveness of sublingual immunotherapy for house dust mite-induced allergic rhinitis and its co-morbid conditions. Immunotherapy. 2019;11(16):1387–1397.
   PubMed Web of Science ®Google Scholar
• Nolte H, Bernstein DI, Nelson HS, et al. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2016;138(6):1631–1638.
   PubMed Web of Science ®Google Scholar
• Xian M, Feng M, Dong Y, et al. Changes in CD4+CD25+FoxP3+ regulatory t cells and serum cytokines in sublingual and subcutaneous immunotherapy in allergic rhinitis with or without Asthma. Int Arch Allergy Immunol. 2020;181(1):71–80.
   PubMed Web of Science ®Google Scholar
• Pfaar O, Bachert C, Kuna P, et al. Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma. J Allergy Clin Immunol. 2019;143(3):970–977.
   PubMed Web of Science ®Google Scholar
• Ünal D. Effects of perennial allergen immunotherapy in allergic rhinitis in patients with/without asthma: a-randomized controlled real-life study. Int Arch Allergy Immunol. 2020;181(2):141–148.
   PubMed Web of Science ®Google Scholar
• O’Hehir RE, Varese NP, Deckert K, et al. Epidemic thunderstorm asthma protection with five-grass pollen tablet sublingual immunotherapy: a clinical trial. Am J Respir Crit Care Med. 2018;198(1):126–128.
   PubMed Web of Science ®Google Scholar
• Mosbech H, Deckelmann R, de Blay F, et al. Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2014;134(568–575.e7):568–575.e7.
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Canonica GW, Bagnasco D. Benefit of SLIT and SCIT for allergic rhinitis and Asthma. Curr Allergy Asthma Rep. 2016;16(12):88.
   PubMed Web of Science ®Google Scholar
• Virchow JC, Backer V, Kuna P, et al. Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial. JAMA. 2016;315(16):1715–1725.
   PubMed Web of Science ®Google Scholar
• Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev. 2010;8:CD001186. DOI:10.1002/14651858.CD001186.pub2
   PubMed Web of Science ®Google Scholar
• Kikkawa S, Nakagome K, Kobayashi T, et al. Sublingual Immunotherapy for Japanese cedar pollinosis attenuates asthma exacerbation. Allergy Asthma Immunol Res. 2019;11(3):438–440.
   PubMed Web of Science ®Google Scholar
• Wahn U, Bachert C, Heinrich J, et al. Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma. Allergy. 2019;74(3):594–604.
   PubMed Web of Science ®Google Scholar
• Zielen S, Devillier P, Heinrich J, et al. Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: a retrospective, real-world database analysis. Allergy. 2018;73(1):165–177.
   PubMed Web of Science ®Google Scholar
• Mösges R, Bachert C, Panzner P, et al. Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: a randomized, multicenter, double-blind, placebo-controlled trial. Allergy. 2018;73(9):1842–1850.
   PubMed Web of Science ®Google Scholar
• Okamoto Y, Fujieda S, Okano M, et al. House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis. Allergy. 2017;72(3):435–443.
   PubMed Web of Science ®Google Scholar
• Filanowicz M, Szynkiewicz E, Cegła B, et al. Analysis of the quality of life of patients with asthma and allergic rhinitis after immunotherapy. Postepy Dermatol Alergol. 2016;33:134–141.
   PubMed Web of Science ®Google Scholar
• Gunawardana NC, Durham SR. New approaches to allergen immunotherapy. Ann Allergy Asthma Immunol. 2018;121(3):293–305.
   PubMed Web of Science ®Google Scholar
• Senti G, Freiburghaus AU, Larenas-Linnemann D, et al. Intralymphatic Immunotherapy: Update and unmet needs. Int Arch Allergy Immunol. 2019;178(2):141–149.
   PubMed Web of Science ®Google Scholar
• Senti G, Kündig TM. Novel delivery routes for allergy immunotherapy: intralymphatic, epicutaneous, and intradermal. Immunol Allergy Clin North Am. 2016;36(1):25–37.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. New directions in allergic diseases: mechanism-based anti-inflammatory therapies. J Allergy Clin Immunol. 2000;106(1):5–16.
   PubMed Web of Science ®Google Scholar
• Watts AM, Cripps AW, West NP, et al. Modulation of allergic inflammation in the nasal mucosa of allergic rhinitis sufferers with topical pharmaceutical agents. Front Pharmacol. 2019;10:294. eCollection 2019.
   PubMed Web of Science ®Google Scholar
• Chen H, Lou H, Wang Y, et al. Comparison of the efficacy and mechanisms of intranasal budesonide, montelukast, and their combination in treatment of patients with seasonal allergic rhinitis. Int Forum Allergy Rhinol. 2018;8(11):1242–1252.
   PubMed Web of Science ®Google Scholar
• Lohia S, Schlosser RJ, Soler ZM. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis. Allergy. 2013;68:569–579.
   PubMed Web of Science ®Google Scholar
• Henriksen JM, Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am Rev Respir Dis. 1984;130(6):1014–1018.
   PubMed Web of Science ®Google Scholar
• Corren J, Adinoff AD, Buchmeier AD, et al. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol. 1992;90(2):250–256.
   PubMed Web of Science ®Google Scholar
• Dahl R, Nielsen LP, Kips J, et al. Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma. Allergy. 2005;60(7):875–881.
   PubMed Web of Science ®Google Scholar
• Church MK, Church DS. Pharmacology of antihistamines. Indian J Dermatol. 2013;58(3):219–224.
   PubMedGoogle Scholar
• Randall KL, Hawkins CA. Antihistamines and allergy. Aust Prescr. 2018;41(2):41–45.
   PubMed Web of Science ®Google Scholar
• Mansmann HC, Altman RA, Berman BA, et al. Efficacy and safety of cetirizine therapy in perennial allergic rhinitis. Ann Allergy. 1992;68(4):348–353.
   PubMedGoogle Scholar
• Simons FER. Advances in H1 Antihistamines. N Engl J Med. 2004;351(21):2203–2217.
   PubMed Web of Science ®Google Scholar
• Simons FER, Simons KJ. Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol. 2011;128(1139–1150.e4):1139–1150.e4.
   Google Scholar
• Layton D, Wilton L, Boshier A, et al. Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England. Drug Saf. 2006;29(10):897–909.
   PubMed Web of Science ®Google Scholar
• Ja W, RL K, Ak E, et al. A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis. Ann Allergy Asthma Immunol. 2003;9:375–385.
   Google Scholar
• Church MK, Tiongco-Recto M, Ridolo E, et al. Bilastine: a lifetime companion for the treatment of allergies. Curr Med Res Opin. 2020;36(3):445–454.
   PubMed Web of Science ®Google Scholar
• Kuna P, Bachert C, Nowacki Z, et al. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study. Clin Exp Allergy. 2009;39(9):1338–1347.
   PubMed Web of Science ®Google Scholar
• Bustos GJ, Bustos D, Bustos GJ, et al. Prevention of asthma with ketotifen in preasthmatic children: a three-year follow-up study. Clin Exp Allergy. 1995;25:568–573.
   PubMed Web of Science ®Google Scholar
• Crystal-Peters J, Neslusan C, Crown WH, et al. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol. 2002;109(1):57–62.
   PubMed Web of Science ®Google Scholar
• Simons FE. Is antihistamine (H1-receptor antagonist) therapy useful in clinical asthma? Clin Exp Allergy. 1999;29(Suppl 3):98–104.
   PubMed Web of Science ®Google Scholar
• Grant JA, Nicodemus CF, Findlay SR, et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol. 1995;95(5):923–932.
   PubMed Web of Science ®Google Scholar
• Baena-Cagnani CE, Berger WE, DuBuske LM, et al. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of β2-agonists in patients with seasonal allergic rhinitis and Asthma. Int Arch Allergy Immunol. 2003;130(4):307–313.
   PubMed Web of Science ®Google Scholar
• Berger WE, Schenkel EJ, Mansfield LE, et al. Desloratadine Study Group. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion. Ann Allergy Asthma Immunol. 2002;89(5):485–491.
   PubMed Web of Science ®Google Scholar
• Pasquali M, Baiardini I, Rogkakou A, et al. Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. Clin Exp Allergy. 2006;36(9):1161–1167.
   PubMed Web of Science ®Google Scholar
• Bachert C, Maspero J. Efficacy of second-generation antihistamines in patients with allergic rhinitis and comorbid asthma. J Asthma. 2011;48(9):965–973.
   PubMed Web of Science ®Google Scholar
• Corren J, Harris AG, Aaronson D, et al. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol. 1997;100(6):781–788.
   PubMed Web of Science ®Google Scholar
• Corren J, Storms W, Bernstein J, et al. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. Clin Ther. 2005;27(5):543–553.
   PubMed Web of Science ®Google Scholar
• Du K, Qing H, Zheng M, et al. Intranasal antihistamine is superior to oral H1 antihistamine as an add-on therapy to intranasal corticosteroid for treating allergic rhinitis. Ann Allergy Asthma Immunol. 2020;125(589–596.e3):589–596.e3.
   PubMed Web of Science ®Google Scholar
• Hampel FC, Pedinoff AJ, Jacobs RL, et al. Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis. Allergy Asthma Proc. 2019;40(4):261–272.
   PubMed Web of Science ®Google Scholar
• Gross GN, Berman G, Amar NJ, et al. Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2019;122(630–638.e3):630–638.e3.
   PubMed Web of Science ®Google Scholar
• Price D, Klimek L, Gálffy G, et al. Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma. Clin Mol Allergy. 2020;18(1):15.
   PubMedGoogle Scholar
• Krishnamoorthy M, Mohd Noor N, Mat Lazim N, et al. Efficacy of montelukast in allergic rhinitis treatment: a systematic review and meta-analysis. Drugs. 2020;80(17):1831–1851.
   PubMed Web of Science ®Google Scholar
• Price DB, Swern A, Tozzi CA, et al. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy. 2006;61(6):737–742.
   PubMed Web of Science ®Google Scholar
• Reicin A, White R, Weinstein SF, et al. Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma. Arch Intern Med. 2000;160(16):2481–2488.
   PubMedGoogle Scholar
• Kim M-K, Lee SY, Park H-S, et al. A randomized, multicenter, double-blind, phase iii study to evaluate the efficacy on allergic rhinitis and safety of a combination therapy of montelukast and levocetirizine in patients with asthma and allergic rhinitis. Clin Ther. 2018;40(1096–1107.e1):1096–1107.e1.
   Google Scholar
• Vignola AM, Humbert M, Bousquet J, et al. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Allergy. 2004;59(7):709–717.
   PubMed Web of Science ®Google Scholar
• Weinstein SF, Katial R, Jayawardena S, et al. Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma. J Allergy Clin Immunol. 2018;142(171–177.e1): 171–177.e1.
   PubMed Web of Science ®Google Scholar
• Yu C, Wang K, Cui X, et al. Clinical efficacy and safety of omalizumab in the treatment of allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials. Am J Rhinol Allergy. 2020;34(2):196–208.
   PubMed Web of Science ®Google Scholar
• Humbert M, Boulet LP, Niven RM, et al. Omalizumab therapy: patients who achieve greatest benefit for their asthma experience greatest benefit for rhinitis. Allergy. 2009;64(1):81–84.
   PubMed Web of Science ®Google Scholar
• Kopp MV, Hamelmann E, Zielen S, et al. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma. Clin Exp Allergy. 2009;39(2):271–279.
   PubMed Web of Science ®Google Scholar
• Okubo K, Okano M, Sato N, et al. Add-on omalizumab for inadequately controlled severe pollinosis despite standard-of-care: a randomized study. J Allergy Clin Immunol Pract. 2020;8(3130–3140.e2):3130–3140.e2.
   Google Scholar
• Dupixent-epar-product-information.pdf. [cited 2020 Dec 20]. Available from: www.ema.europa.eu/en/documents/product-information/dupixent-epar-product-information_en.pdf. Date last accessed: Dec 10, 2020
   Google Scholar
• Wenzel S, Castro M, Corren J, et al. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lancet. 2016;388(10039):31–44.
   PubMed Web of Science ®Google Scholar
• Busse WW, Maspero JF, Lu Y, et al. Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2020;125(565–576.e1):565–576.e1.
   Google Scholar
• Licari A, Castagnoli R, De Filippo M, et al. Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis. Expert Opin Biol Ther. 2020;20(6):609–619.
   PubMed Web of Science ®Google Scholar
• Vandenplas O, Godet J, Hurdubaea L, et al. Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma? Allergy. 2018;74(2):261–272.
   PubMed Web of Science ®Google Scholar
• Vandenplas O, Hox V, Bernstein D. Occupational rhinitis. J Allergy Clin Immunol Pract. 2020;8(10):3311–3321.
   PubMed Web of Science ®Google Scholar
• Moscato G, Pala G, Folletti I, et al. Occupational rhinitis affects occupational asthma severity. J Occup Health. 2016;58(3):310–313.
   PubMed Web of Science ®Google Scholar
• Shusterman D. Nonallergic rhinitis: environmental determinants. Immunol Allergy Clin North Am. 2016;36(2):379–399.
   PubMed Web of Science ®Google Scholar
• Powell H, Murphy VE, Hensley MJ, et al. Rhinitis in pregnant women with asthma is associated with poorer asthma control and quality of life. J Asthma. 2015;52(10):1023–1030.
   PubMed Web of Science ®Google Scholar
• Wei J, Gerlich J, Genuneit J, et al. Hormonal factors and incident asthma and allergic rhinitis during puberty in girls. Ann Allergy Asthma Immunol. 2015;115(21–27.e2):21–27.e2.
   PubMed Web of Science ®Google Scholar
• Bonham CA, Patterson KC, Strek ME. Asthma outcomes and management during pregnancy. Chest. 2018;153(2):515–527.
   PubMed Web of Science ®Google Scholar
• Lal D, Jategaonkar AA, Borish L, et al. Management of rhinosinusitis during pregnancy: systematic review and expert panel recommendations. Rhinology. 2016;54(2):99–104.
   PubMed Web of Science ®Google Scholar
• Subramanian H, Gupta K, Ali H. Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases. J Allergy Clin Immunol. 2016;138(3):700–710.
   PubMed Web of Science ®Google Scholar
• Settipane RA. Other causes of rhinitis: mixed rhinitis, rhinitis medicamentosa, hormonal rhinitis, rhinitis of the elderly, and gustatory rhinitis. Immunol Allergy Clin North Am. 2011;31(3):457–467.
   PubMed Web of Science ®Google Scholar
• Rodriguez K, Rubinstein E, Ferguson BJ. Clear anterior rhinorrhea in the population. Int Forum Allergy Rhinol. 2015;5(11):1063–1067.
   PubMed Web of Science ®Google Scholar
• Morais-Almeida M, Pite H, Pereira AM, et al. Prevalence and classification of rhinitis in the elderly: a nationwide survey in Portugal. Allergy. 2013;68(10):1150–1157.
   PubMed Web of Science ®Google Scholar
• Van Gerven L, Alpizar YA, Wouters MM, et al. Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis. J Allergy Clin Immunol. 2014;133(5):1332–1339.
   PubMed Web of Science ®Google Scholar
• Fokkens W, Hellings P, Segboer C. Capsaicin for rhinitis. Curr Allergy Asthma Rep. 2016;16(8):60.
   PubMed Web of Science ®Google Scholar
• Gevorgyan A, Segboer C, Gorissen R, et al. Capsaicin for non-allergic rhinitis. Cochrane Database Syst Rev. 2015;7:CD010591. DOI:10.1002/14651858.CD010591.pub2
   PubMed Web of Science ®Google Scholar
• Bose S, Grammer LC, Peters AT. Infectious chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2016;4(4):584–589.
   PubMed Web of Science ®Google Scholar
• Piromchai P, Thanaviratananich S, Laopaiboon M. Systemic antibiotics for chronic rhinosinusitis without nasal polyps in adults. Cochrane Database Syst Rev. 2016 Apr;25(4):CD008233.
   Google Scholar
• Huang Z, Zhou B. Clarithromycin for the treatment of adult chronic rhinosinusitis: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2019;9(5):545–555.
   PubMed Web of Science ®Google Scholar
• Lim M, Citardi MJ, Leong J-L. Topical antimicrobials in the management of chronic rhinosinusitis: a systematic review. Am J Rhinol. 2008;22:381–389.
   PubMedGoogle Scholar
• Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol. 2014;113:347–385.
   PubMed Web of Science ®Google Scholar
• Subramanian HN, Schechtman KB, Hamilos DL. A retrospective analysis of treatment outcomes and time to relapse after intensive medical treatment for chronic sinusitis. Am J Rhinol. 2002;16(6):303–312.
   PubMedGoogle Scholar
• Lal D, Scianna JM, Stankiewicz JA. Efficacy of targeted medical therapy in chronic rhinosinusitis, and predictors of failure. Am J Rhinol Allergy. 2009;23(4):396–400.
   PubMed Web of Science ®Google Scholar
• Ryu G, Min C, Park B, et al. Bidirectional association between asthma and chronic rhinosinusitis: two longitudinal follow-up studies using a national sample cohort. Sci Rep. 2020;10(1):9589.
   PubMed Web of Science ®Google Scholar
• Gleadhill C, Speth MM, Gengler I, et al. Chronic rhinosinusitis disease burden is associated with asthma-related emergency department usage. Eur Arch Otorhinolaryngol. 2020;278(1):93–99.
   PubMedGoogle Scholar
• Kim Y-C, Won H-K, Lee JW, et al. Staphylococcus aureus nasal colonization and asthma in adults: Systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2019;7(606–615.e9):606–615.e9.
   Google Scholar
• Wu D, Bleier B, Wei Y. Definition and characteristics of acute exacerbation in adult patients with chronic rhinosinusitis: a systematic review. J Otolaryngol Head Neck Surg. 2020;49(1):62.
   PubMed Web of Science ®Google Scholar
• Kwah JH, Somani SN, Stevens WW, et al. Clinical factors associated with acute exacerbations of chronic rhinosinusitis. J Allergy Clin Immunol. 2020;145(6):1598–1605.
   PubMed Web of Science ®Google Scholar
• Farhood Z, Schlosser RJ, Pearse ME, et al. Twenty-two-item sino-nasal outcome test in a control population: a cross-sectional study and systematic review. Int Forum Allergy Rhinol. 2016;6(3):271–277.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Kanda A, Yun Y, et al. Reduced local response to corticosteroids in eosinophilic chronic rhinosinusitis with Asthma. Biomolecules. 2020;10(2):326.
   Web of Science ®Google Scholar
• Dixon AE, Castro M, Cohen RI, et al. Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma. J Allergy Clin Immunol. 2015;135(701–709.e5):701–709.e5.
   PubMed Web of Science ®Google Scholar
• Gibson PG, Yang IA, Upham JW, et al. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet. 2017;390(10095):659–668.
   PubMed Web of Science ®Google Scholar
• Tiotiu A, Salvator H, Jaussaud R, et al. Efficacy of immunoglobulin replacement therapy and azithromycin in severe asthma with antibody deficiency. Allergol Int. 2020;69(2):215–222.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Bansal S, Chakrabarti A. Are allergic fungal rhinosinusitis and allergic bronchopulmonary aspergillosis lifelong conditions? Med Mycol. 2017;55(1):87–95.
   PubMed Web of Science ®Google Scholar
• Denning DW, Chakrabarti A. Pulmonary and sinus fungal diseases in non-immunocompromised patients. Lancet Infect Dis. 2017;17(11):e357–66.
   PubMed Web of Science ®Google Scholar
• Barac A, Ong DSY, Jovancevic L, et al. Lower respiratory tract allergic diseases: one entity. Front Microbiol. 2018;9:583.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Dhooria S, Sehgal IS, et al. A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J. 2018;52(3):1801159.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Dhooria S, Singh Sehgal I, et al. A randomized trial of itraconazole vs prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating Asthma. Chest. 2018;153(3):656–664.
   PubMed Web of Science ®Google Scholar
• Eraso IC, Sangiovanni S, Morales EI, et al. Use of monoclonal antibodies for allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis: literature review. Ther Adv Respir Dis. 2020;14:1753466620961648.
   Web of Science ®Google Scholar
• Matsumoto N, Shigekusa T, Matsuo A, et al. Allergic bronchopulmonary aspergillosis complicated by eosinophilic chronic rhinosinusitis successfully treated with mepolizumab. Respirol Case Rep. 2019;7(7):e00465.
   PubMed Web of Science ®Google Scholar